RapidArc Radiosurgery technology is designed to be used on the company’s TrueBeam STx system for treating early-stage inoperable lung cancer and many thoracic tumors.
The technology facilitates clinicians to target and treat tumors non-invasively by using X-ray beams.
Varian senior director surgical sciences Calvin Huntzinger said research has been accruing to show that radiosurgery can be a viable option for early-stage, inoperable lung cancer patients.
"In addition, a major NCI-funded study is under way to see if that viability extends to high-risk operable Stage I lung cancer patients," Huntzinger added.
